These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12431852)

  • 21. A controlled positron emission tomography study of obsessive and neutral auditory stimulation in obsessive-compulsive disorder with checking rituals.
    Cottraux J; Gérard D; Cinotti L; Froment JC; Deiber MP; Le Bars D; Galy G; Millet P; Labbé C; Lavenne F; Bouvard M; Mauguière F
    Psychiatry Res; 1996 Mar; 60(2-3):101-12. PubMed ID: 8723300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extended-release fluvoxamine and improvements in quality of life in patients with obsessive-compulsive disorder.
    Koran LM; Bromberg D; Hornfeldt CS; Shepski JC; Wang S; Hollander E
    Compr Psychiatry; 2010; 51(4):373-9. PubMed ID: 20579510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacotherapy and regional cerebral blood flow in children with obsessive compulsive disorder.
    Diler RS; Kibar M; Avci A
    Yonsei Med J; 2004 Feb; 45(1):90-9. PubMed ID: 15004874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decrease of prefrontal metabolism after subthalamic stimulation in obsessive-compulsive disorder: a positron emission tomography study.
    Le Jeune F; Vérin M; N'Diaye K; Drapier D; Leray E; Du Montcel ST; Baup N; Pelissolo A; Polosan M; Mallet L; Yelnik J; Devaux B; Fontaine D; Chereau I; Bourguignon A; Peron J; Sauleau P; Raoul S; Garin E; Krebs MO; Jaafari N; Millet B;
    Biol Psychiatry; 2010 Dec; 68(11):1016-22. PubMed ID: 20951978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain reactivity to specific symptom provocation indicates prospective therapeutic outcome in OCD.
    Hendler T; Goshen E; Tzila Zwas S; Sasson Y; Gal G; Zohar J
    Psychiatry Res; 2003 Oct; 124(2):87-103. PubMed ID: 14561427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional neuroanatomy of obsessive-compulsive disorder.
    Trivedi MH
    J Clin Psychiatry; 1996; 57 Suppl 8():26-35; discussion 36. PubMed ID: 8698677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.
    Freeman CP; Trimble MR; Deakin JF; Stokes TM; Ashford JJ
    J Clin Psychiatry; 1994 Jul; 55(7):301-5. PubMed ID: 8071291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The comparison of pre- and post-treatment (99m)Tc HMPAO brain SPECT images in patients with obsessive-compulsive disorder.
    Karadağ F; Kalkan Oğuzhanoğlu N; Yüksel D; Kıraç S; Cura C; Ozdel O; Ateşci F
    Psychiatry Res; 2013 Aug; 213(2):169-77. PubMed ID: 23149026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacotherapy of obsessive compulsive disorder.
    Goodman WK; McDougle CJ; Price LH
    J Clin Psychiatry; 1992 Apr; 53 Suppl():29-37. PubMed ID: 1532962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacotherapy response and regional cerebral blood flow characteristics in patients with obsessive-compulsive disorder.
    Wen SL; Cheng MH; Cheng MF; Yue JH; Wang H
    Behav Brain Funct; 2013 Jul; 9():31. PubMed ID: 23898909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroanatomical characteristics associated with response to dorsal anterior cingulotomy for obsessive-compulsive disorder.
    Banks GP; Mikell CB; Youngerman BE; Henriques B; Kelly KM; Chan AK; Herrera D; Dougherty DD; Eskandar EN; Sheth SA
    JAMA Psychiatry; 2015 Feb; 72(2):127-35. PubMed ID: 25536384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic imaging of anterior capsular stimulation in refractory obsessive-compulsive disorder: a key role for the subgenual anterior cingulate and ventral striatum.
    Van Laere K; Nuttin B; Gabriels L; Dupont P; Rasmussen S; Greenberg BD; Cosyns P
    J Nucl Med; 2006 May; 47(5):740-7. PubMed ID: 16644742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Morphometric brain characterization of refractory obsessive-compulsive disorder: diffeomorphic anatomic registration using exponentiated Lie algebra.
    Tang W; Li B; Huang X; Jiang X; Li F; Wang L; Chen T; Wang J; Gong Q; Yang Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():126-31. PubMed ID: 23876787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced thickness of anterior cingulate cortex in obsessive-compulsive disorder.
    Kühn S; Kaufmann C; Simon D; Endrass T; Gallinat J; Kathmann N
    Cortex; 2013 Sep; 49(8):2178-85. PubMed ID: 23067727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single photon emission computed tomography of the brain with Tc-99m HMPAO during sumatriptan challenge in obsessive-compulsive disorder: investigating the functional role of the serotonin auto-receptor.
    Stein DJ; Van Heerden B; Wessels CJ; Van Kradenburg J; Warwick J; Wasserman HJ
    Prog Neuropsychopharmacol Biol Psychiatry; 1999 Aug; 23(6):1079-99. PubMed ID: 10621951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [18F]FDG PET study in obsessive-compulsive disorder. A clinical/metabolic correlation study after treatment.
    Perani D; Colombo C; Bressi S; Bonfanti A; Grassi F; Scarone S; Bellodi L; Smeraldi E; Fazio F
    Br J Psychiatry; 1995 Feb; 166(2):244-50. PubMed ID: 7728370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluvoxamine treatment and D2 receptors: a pet study on OCD drug-naïve patients.
    Moresco RM; Pietra L; Henin M; Panzacchi A; Locatelli M; Bonaldi L; Carpinelli A; Gobbo C; Bellodi L; Perani D; Fazio F
    Neuropsychopharmacology; 2007 Jan; 32(1):197-205. PubMed ID: 17019408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Change characteristics of regional cerebral blood flow and curative efficacy in patients with obsessive-compulsive disorder].
    Wen SL; Yue JH; Cheng MF; Cheng MH
    Zhonghua Yi Xue Za Zhi; 2012 Jul; 92(27):1896-900. PubMed ID: 23134961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A controlled trial of lithium augmentation in fluvoxamine-refractory obsessive-compulsive disorder: lack of efficacy.
    McDougle CJ; Price LH; Goodman WK; Charney DS; Heninger GR
    J Clin Psychopharmacol; 1991 Jun; 11(3):175-84. PubMed ID: 1820757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overvalued ideation as a predictor of fluvoxamine response in patients with obsessive-compulsive disorder.
    Neziroglu F; Pinto A; Yaryura-Tobias JA; McKay D
    Psychiatry Res; 2004 Jan; 125(1):53-60. PubMed ID: 14967552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.